Transparency, Patient Assistance Requirements Needed in 340B, Say Drugmaker-Backed Groups

Justin Leventhal
Justin Leventhal, a senior policy analyst for the American Consumer Institute, has advocated for more 340B transparency alongside other drugmaker-backed groups.
Amid ongoing congressional legislative proposals to boost transparency and other requirements for 340B hospitals, two advocacy groups that receive drugmaker [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Could the States Resolve the Contract Pharmacy Impasse?

340B Report Publisher and CEO Ted Slafsky addresses enforcement actions and litigation surrounding state 340B contract pharmacy laws in his latest column.
After a recent lull in the ongoing battle over whether drug manufacturers can continue to place restrictions on access to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Split on 340B Medicaid Provisions in Major House Healthcare Package

Joe Dunn, senior vice president of public policy and research at NACHC, said his organization supported the Lower Costs, More Transparency Act.
Provider groups diverged over 340B Medicaid managed care provisions in a sweeping healthcare package on which the House of Representatives [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Uncertain Outlook for GOP Drug Shortages Bill with 340B Provisions

Rep. Anna Eshoo, ranking member of the E&C Health Subcommittee, was one of multiple Democrats opposed to a Republican drug shortages bill.
The future of a Republican drug shortages bill with 340B provisions remains unclear after it was examined in a contentious [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

House Subcommittee Clashes Over 340B Role in Drug Shortages

Rep. Cathy McMorris Rodgers
Legislation sponsored by Rep. Cathy McMorris Rodgers (R-Wash.) was the focus of a partisan clash during a Sept. 14 hearing over changes it would implement for the 340B program.
A House subcommittee hearing today exposed partisan divisions over the 340B program’s impact on generic drug shortages. The Sep. 14 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Coming Major GOP Healthcare Package Includes 340B Medicaid Provisions

The House Appropriations Committee approved the Labor, Health and Human Services, Education and Related Agencies Appropriations Act on July 10.
Republican House leaders were expected introduce—as soon as Sept. 8—and quickly advance a combined package of healthcare bills that includes [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Appeals Court Decision May Threaten Some State Health Plan Regulations, 340B Protections

A federal appeals court struck down parts of an Oklahoma PBM law, which could create a legal gray area for certain 340B protections.
A federal appeals court decision striking down parts of an Oklahoma pharmacy benefit manager (PBM) law could jeopardize state laws [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Provider Groups Oppose 340B Provisions in Committee Chair’s Drug Shortage Bill

House E&C wordmark
Provider groups criticized draft legislation to address drug shortages from the House Energy and Commerce Committee.
Draft legislation that would exclude some generics from 340B and focus on penny pricing recently drew criticism from provider advocates. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Claims Clearinghouse, Strengthening HRSA Among Few Consensus Areas in Responses to Senate 340B Overhaul Effort

Sen. John Thune
Sen. John Thune is part of a bipartisan group of six senators that solicited stakeholder advice on strategies to reform the 340B program.
The creation of a claims clearinghouse and increasing both the funding and authority of the federal agency overseeing the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

House E&C GOP Leaders’ Draft Bill Would Exempt Sterile Generic Injectables from 340B Pricing Requirements

House Energy & Commerce Committee's draft bill.
GOP leaders on the House Energy & Commerce Committee released a draft bill to address drug shortages that includes a provision that would exempt certain drug products from 340B pricing requirements.
Republican leaders of the U.S. House Energy and Commerce (E&C) Committee released a draft bill late last week that would [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live